Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a86884a281850ba8aa79320c2a0fa78a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b69e45ab1c5ed0e079b66ab5321b66c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0703e46ab8e74746c8cf4919a5d9926 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ccfbce2e832d5a44ff425a4ef250ed |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-40 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3695 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
filingDate |
2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb0c1a5e22b248f21d3aec8ca07c022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63d4d461f0db065b56dcf85ee94ad298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12459c9a0f485855dd9db76458c16107 |
publicationDate |
2016-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9510933-B2 |
titleOfInvention |
Acellular vascular products |
abstract |
A product comprising a natural acellular xenogenic vascular tissue matrix having at least an 80% reduction in DNA content as compared to an untreated control vascular tissue matrix and being antigenically inert by being substantially free of epitopes capable of reacting with pre-formed human antibodies and also without having the ability to substantially activate complement. The invention also includes methods of preparing such products and uses of the products especially in bypass surgery. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413375-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406736-B2 |
priorityDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |